CELU 250117 1.50P (CELU250117P1500) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Jan 21 09:30 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Dec 10, 2024 07:09

NEWS

$Celularity (CELU.US)$
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
Tuesday, 10th December at 8:00 am
FLORHAM PARK, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) ("Celularity" or the "Company"), a regenerative and cellular medicine company, today announced that it has received a letter from the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq"), confirming that Celularity has regained compliance with Nasdaq Listing ...

Jaguar8

Dec 8, 2024 02:14

🟢Watchlist December 9 Monday. Trading a stock is YOUR DECISION and you should be SOLELY ACCOUNTABLE for it. NFA.

$MSP Recovery (LIFW.US)$ Ticker change to MSPR Monday to consolidate services. Even with negative profit margin, of note, company had $10M settlements from property and casualty insurers and acquired Medicare claims valued $10.6B. Low float. Currently trading above 10/20 EMA suggesting short term bullishness. SI 162%, 0 shares LTB
$Roth CH Acquisition V Co(Delisted) (ROCL.US)$ Ticker change tomorr...

Jaguar8

Dec 6, 2024 07:55

Impressive ER

$Celularity (CELU.US)$

Jaguar8

Dec 6, 2024 07:02

NEWS

$Celularity (CELU.US)$
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023
Friday, 6th December at 8:00 am
• Celularity filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024, and is now current with its quarterly report filings
• Reported Total Net Revenue for the Three Months and the Nine Months ending September 30, 2024, are consistent with last guidance, with significant growth over the same perio...

Trytosaveabit

Dec 6, 2024 07:01

Nice

$Celularity (CELU.US)$ Press Release: Celularity Reports Over Sevenfold Growth in Net Product Sales Through Third Quarter 2024 Compared to Third Quarter 2023
Dow Jones· just
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023
-- Celularity filed its Quarterly Report on Form 10-Q for the period ended
September 30, 2024, and is now current with its quarterly report filings
-- Reported Total Net Revenue for the Three Months an...